CPR Invest - European Strategic Autonomy - R EUR - Acc ISIN : LU2570611165
CPR Invest - European Strategic Autonomy - R EUR - Acc
R EUR(C) - LU2570611165
Asset class: Equities
YTD
As of 13/11/20268.81%
Risk IndicatorThe level of risk of the fund mainly reflects the risk of the market in which the fund is invested and, as the case may be, the leveraging strategy or inverse performance of the index. The capital initially invested does not benefit from any guarantee. The current level of risk does not indicate the future level of risk and may change over time. The lowest risk level is not equal to a risk-free investment.
1234567
Lower Risk
Higher Risk
The risk indicator assumes you keep the product according to the holding period.
NAV
As of 13/11/2026€179.35
SFDR ClassificationSustainable Finance Disclosure Regulation
Art. 8
Fund AUM
As of 13/11/2026€1.14B
The investment objective is to outperform European equity markets over a long-term period (minimum of five years) by investing in equities involved in strategic sectors that contribute to Europe’s autonomy and resilience, while integrating Environmental, Social and Governance (ESG) criteria in the investment process.
NAVs
NAV from 25/04/2024 to 13/11/2026
Select period
Performance
Change in NAV in base 100
FundCPR Invest - European Strategic Autonomy - R EUR - Acc (31.78% over the period)
Select period
Change in NAV in base 100Rolling performancesYear-on-year return (365 days)Annual returnsRisk indicatorsPerformances Scenarios
FundCPR Invest - European Strategic Autonomy - R EUR - Acc (31.78% over the period)
Select period
Portfolio Analysis
Repartition 10/31/2026
Main Lines in Portfolio (Source: Amundi)Geographical breakdown (Source: Amundi)CurrencySector allocation
Sector | Weight | Spread / Index | |
|---|---|---|---|
| ASML HOLDING NV | Information Technology | 7.91% | -1.04% |
| SIEMENS AG-REG | Industrials | 3.29% | 0.25% |
| BANCO SANTANDER SA MADRID | Financials | 3.25% | 0.95% |
| AIRBUS SE PARIS | Industrials | 2.91% | 1.12% |
| SAP SE / XETRA | Information Technology | 2.83% | -0.42% |
| ALLIANZ SE-REG | Financials | 2.67% | 0.11% |
| COMPAGNIE DE SAINT GOBAIN | Industrials | 2.67% | 2.21% |
| SAFRAN SA | Industrials | 2.50% | 1.03% |
| COMMERZBANK AG | Financials | 2.45% | 2.10% |
| SCHNEIDER ELECT SE | Industrials | 2.43% | 0.34% |
Management commentary
Effective date: 31/10/2026
In October, the fund recorded a performance of -3.13%, compared to -1.58% for the MSCI EMU Net Total Return index. Year-to-date, the fund is up 6.41%, versus 9.06% for its benchmark index.
The start of the season was particularly eventful, both from a geopolitical perspective with the ongoing stalemate between the United States and Iran. President Trump publicly hinted that the time for a decision was approaching, wavering between concluding an agreement or resuming military operations against Tehran. The price of a barrel continued its upward trajectory begun in June, with a monthly increase of 13.6%. Brent futures are now trading at $100 levels until next May. Inflation therefore remains high; in Europe, it was 3.8%, driven by energy prices. In this context, purchasing power is deteriorating and protests have multiplied across Europe, particularly in France. Added to this were concerns related to AI financing. The catalyst was the surge in Coreweave’s CDS. The risk of a credit bubble forming in Neoclouds had a contagion effect across the entire technology sector. The dependence on capex and the credit market to finance them is worrying.
In this context, stocks related to electrification were heavily penalized both within technology (ASML, ASMI, and Infineon down by 11.41%, 17.82%, and 15.03% respectively) and within industrials (Siemens Energy, Legrand, Prysmian down by 11%, 10.97%, and 7.49%). The defense sector rebounded slightly, but engine manufacturers suffered particularly from tensions in oil prices; thus, Safran and Roll-Royce fell by 17.55% and 12.99%. The healthcare sector, as in the previous month, was a detractor, with significant declines from Abivax and Ottobock, down by -9.97% and -9.32% respectively.
Ingredients performed well over the month following strong earnings releases; DSM and Novonesis rose by 9.4% and 10.16%.
Regarding portfolio movements, we slightly increased our position in Safran after its earnings release. We initiated a position in EssilorLuxottica by selling our Carrefour shares.
The start of the season was particularly eventful, both from a geopolitical perspective with the ongoing stalemate between the United States and Iran. President Trump publicly hinted that the time for a decision was approaching, wavering between concluding an agreement or resuming military operations against Tehran. The price of a barrel continued its upward trajectory begun in June, with a monthly increase of 13.6%. Brent futures are now trading at $100 levels until next May. Inflation therefore remains high; in Europe, it was 3.8%, driven by energy prices. In this context, purchasing power is deteriorating and protests have multiplied across Europe, particularly in France. Added to this were concerns related to AI financing. The catalyst was the surge in Coreweave’s CDS. The risk of a credit bubble forming in Neoclouds had a contagion effect across the entire technology sector. The dependence on capex and the credit market to finance them is worrying.
In this context, stocks related to electrification were heavily penalized both within technology (ASML, ASMI, and Infineon down by 11.41%, 17.82%, and 15.03% respectively) and within industrials (Siemens Energy, Legrand, Prysmian down by 11%, 10.97%, and 7.49%). The defense sector rebounded slightly, but engine manufacturers suffered particularly from tensions in oil prices; thus, Safran and Roll-Royce fell by 17.55% and 12.99%. The healthcare sector, as in the previous month, was a detractor, with significant declines from Abivax and Ottobock, down by -9.97% and -9.32% respectively.
Ingredients performed well over the month following strong earnings releases; DSM and Novonesis rose by 9.4% and 10.16%.
Regarding portfolio movements, we slightly increased our position in Safran after its earnings release. We initiated a position in EssilorLuxottica by selling our Carrefour shares.
Characteristics
General data
Inception date
28/03/2023First Nav Date
25/04/2024Currency
EURShow more
Valuation
DailyMinimum initial investment
1 10/1000° share(s)/equityMinimum additional investment
1 10/1000° share(s)/equityCosts Composition
| One-off costs upon entry or exit (Investment EUR 10,000) | If you exit after 1 year | ||
| Entry costs | This includes distribution costs of 5.00% of amount invested. This is the most you will be charged. The person selling you the product will inform you of the actual charge. | Up to €500.00 | |
| Exit costs | We do not charge an exit fee for this product, but the person selling you the product may do so. | €0.00 | |
| Ongoing costs taken each year (Investment EUR 10,000) | |||
| Management fees and other administrative or operating costs | 1.32% of the value of your investment per year. This percentage is based on actual costs over the last year. | €125.78 | |
| Transaction costs | 0.24% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the underlying investments for the product. The actual amount will vary depending on how much we buy and sell. | €22.86 | |
| Incidental costs taken under specific conditions (Investment EUR 10,000) | |||
| Performance fees | 15.00% annual outperformance of the reference asset 100% MSCI EMU NR Close. The calculation applies on each Net Asset Value calculation date in accordance with the terms described in the prospectus. Past underperformances over the last 5 years should be clawed back before any new accrual of performance fee.The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years. The performance fee is paid even if the performance of the share over the performance observation period is negative, while remaining higher than the performance of the Reference Asset. | €10.17 | |
Codification
ISIN code
LU2570611165Bloomberg code
CPEUSAR LXReuters code
Investment Objective
The investment objective is to outperform European equity markets over a long-term period (minimum of five years) by investing in equities involved in strategic sectors that contribute to Europe’s autonomy and resilience, while integrating Environmental, Social and Governance (ESG) criteria in the investment process.
Documents
| Language | Documents | Type | Closing Date |
|---|
Sustainability-related disclosures
| Language | Documents | Type | Closing Date |
|---|